Intra-Cellular Therapies

YTD

ALL

Why Robinhood?

You can watch ITCI and buy or sell other stocks, ETFs, and their options commission-free!

About ITCI

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system.

CEO

Sharon L. Mates, PhD

CEOSharon L. Mates, PhD

Employees

860

Employees860

Headquarters

Bedminster, New Jersey

HeadquartersBedminster, New Jersey

Founded

2002

Founded2002

Employees

860

Employees860

ITCI Key Statistics

Market cap

14.01B

Market cap14.01B

Price-Earnings ratio

-182.70

Price-Earnings ratio-182.70

Dividend yield

—

Dividend yield—

Average volume

1.90M

Average volume1.90M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$131.98

52 Week high$131.98

52 Week low

$64.09

52 Week low$64.09

People also own

Based on the portfolios of people who own ITCI. This list is generated using Robinhood data, and it’s not a recommendation.